SMTL ID : 4lvt.2 (1 other biounit)

Bcl_2-Navitoclax (ABT-263) Complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

monomer

Ligands

1 x 1XJ: 4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide(Non-covalent)

1XJ.1: 21 residues within 4Å: Chain A: A.59, D.62, F.63, Y.67, D.70, F.71, M.74, V.92, L.96, N.102, W.103, G.104, R.105, V.107, A.108, E.111, F.112, V.115, F.157, L.160, Y.161 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:F.63, A:F.63, A:F.63, A:Y.67, A:M.74, A:V.92, A:V.107, A:F.112 Hydrogen bonds: A:N.102, A:W.103, A:G.104 Water bridges: A:Y.67 Salt bridges: A:D.70

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Souers, A.J. et al., ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. NAT.MED. (N.Y.) (2013)

Release Date

2013-08-14

Peptides

Apoptosis regulator Bcl-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Apoptosis regulator Bcl-2

Related Entries With Identical Sequence